The Clorox Company (NYSE:CLX – Get Free Report) was the recipient of a significant decrease in short interest in November. As of November 30th, there was short interest totalling 3,360,000 shares, a decrease of 10.6% from the November 15th total of 3,760,000 shares. Based on an average daily volume of 1,150,000 shares, the short-interest ratio is currently 2.9 days. Currently, 2.7% of the company’s shares are sold short.
Clorox Stock Performance
CLX stock traded down $1.09 during trading hours on Tuesday, reaching $163.32. The stock had a trading volume of 1,095,319 shares, compared to its average volume of 1,229,642. The stock has a market capitalization of $20.22 billion, a PE ratio of 56.91, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock has a 50-day simple moving average of $163.91 and a 200 day simple moving average of $152.34. Clorox has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.49 earnings per share. Analysts predict that Clorox will post 6.85 EPS for the current fiscal year.
Clorox Dividend Announcement
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the stock. JPMorgan Chase & Co. upped their target price on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Citigroup upped their target price on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and upped their target price for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Five investment analysts have rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $155.38.
Read Our Latest Analysis on Clorox
Hedge Funds Weigh In On Clorox
A number of hedge funds have recently bought and sold shares of the business. Insight Folios Inc increased its position in Clorox by 3.0% during the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after acquiring an additional 63 shares during the period. Fiduciary Group LLC increased its position in Clorox by 0.4% during the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock worth $2,600,000 after acquiring an additional 72 shares during the period. GHP Investment Advisors Inc. increased its holdings in Clorox by 2.0% in the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock valued at $496,000 after buying an additional 72 shares during the period. SPC Financial Inc. increased its holdings in Clorox by 2.2% in the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock valued at $476,000 after buying an additional 75 shares during the period. Finally, Massmutual Trust Co. FSB ADV increased its holdings in Clorox by 17.2% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after buying an additional 75 shares during the period. 78.53% of the stock is owned by institutional investors.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- 10 Best Airline Stocks to Buy
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- 3 Fintech Stocks With Good 2021 Prospects
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Differences Between Momentum Investing and Long Term Investing
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.